Related Experiment Video
Updated: Aug 2, 2026
07:32
Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
Published on: March 16, 2015
Gene-based deafness research: ion transport and hearing
1Department of Otorhinolaryngology, Juntendo University School of Medicine, Tokyo 113-8431, Japan. ike@med.juntendo.ac.jp
The Tohoku Journal of Experimental Medicine
|January 24, 2004
Summary
The cochlea converts sound into electrical signals using ion transport systems. Understanding these transporters, channels, and receptors is key to research on hereditary deafness.
Area of Science:
- Auditory Neuroscience
- Molecular Biology
- Genetics
Background:
- The cochlea is a vital sensory organ responsible for hearing.
- Auditory signal transduction relies heavily on intricate ion transport mechanisms.
- Defects in cochlear function are a primary cause of hearing loss.
Purpose of the Study:
- To review the physiological and molecular biology of cochlear transporters, channels, and receptors.
- To discuss recent genetic research findings related to hereditary deafness.
- To link ion transport mechanisms to genetic causes of hearing impairment.
Main Methods:
- Literature review of physiological studies on cochlear ion transport.
- Analysis of molecular biological data on cochlear expressed proteins.
- Synthesis of findings from genetic research on hereditary deafness.
Main Results:
- Detailed overview of key ion transporters, channels, and receptors in the cochlea.
- Identification of specific molecular players in auditory signal transduction.
- Correlation of genetic mutations with impaired cochlear function.
Conclusions:
- Ion transport systems are fundamental to cochlear sensory function.
- Advances in understanding cochlear molecular biology inform genetic deafness research.
- Targeting ion transport mechanisms may offer future therapeutic strategies for hearing loss.
Related Concept Videos
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...